NOVO ALLE DK 2880, BAGSVAERD DENMARK, G7
CHMP Recommends EU Approval of Wegovy® 7.2 mg in a Single-Dose Pen, Providing Up to 20.7% Mean Weight Loss
Wegovy® pill recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
Material disclosure
Adjusted Operating Profit Reached DKK 32,858 Million in Q1 2026
Share Repurchase Programme
Announces Topline Results from HIBISCUS Trial of Etavopivat in Sickle Cell Disease
Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
No filings found
Amended Schedule 13G - Ownership Report
Annual Report of Employee Stock Purchase
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Iran Notice